Cargando…

Omicron variant of SARS‐CoV‐2, an epidemiologic assessment of pediatric oncology patients in the Bronx

BACKGROUND: Children receiving cytotoxic therapy for cancer have increased risk of infection due to drug‐induced neutropenia and are therefore treated empirically for bacteremia when febrile or ill‐appearing. However, viral infections, which are not frequently life‐threatening, are the most common e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Offenbacher, Rachel, Gorlick, Joshua, Weiser, Daniel A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675379/ https://www.ncbi.nlm.nih.gov/pubmed/36199156 http://dx.doi.org/10.1002/cnr2.1724

Ejemplares similares

Antibody evidence of SARS-CoV-2 infection in healthcare workers in the Bronx
por: Sydney, Elana R., et al.
Publicado: (2020)

Croup Associated With SARS-CoV-2: Pediatric Laryngotracheitis During the Omicron Surge
por: Sharma, Sujit, et al.
Publicado: (2022)

Burden of Pediatric SARS-CoV-2 Hospitalizations during the Omicron Wave in Germany
por: Doenhardt, Maren, et al.
Publicado: (2022)

Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant
por: Gao, Yu, et al.
Publicado: (2022)

Escape of SARS-CoV-2 Variant Omicron to Mucosal Immunity in Vaccinated Subjects
por: Martinuzzi, Emanuela, et al.
Publicado: (2022)

Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants
por: Ong, Chon Phin, et al.
Publicado: (2023)

Clinical Characteristics of 40 Patients Infected With the SARS-CoV-2 Omicron Variant in Korea
por: Kim, Min-Kyung, et al.
Publicado: (2022)

Croup as a Manifestation of SARS-CoV-2 Omicron Variant Infection in Young Children
por: Choi, Youn Young, et al.
Publicado: (2022)

Stability of SARS-CoV-2 variants of concern (Delta and Omicron) on surfaces at room temperature
por: Pottage, Thomas, et al.
Publicado: (2023)

Genomic epidemiology of SARS- CoV-2 Omicron variants in the Republic of Korea
por: Lee, Dong-Wook, et al.
Publicado: (2022)

Clinical Features and Duration of Viral Shedding in Individuals With SARS-CoV-2 Omicron Variant Infection
por: Jang, Young R, et al.
Publicado: (2022)

Prevalence of SARS-CoV-2 Viremia in Presymptomatic Blood Donors in the Delta and Omicron Variant Eras
por: Saá, Paula, et al.
Publicado: (2023)

The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant
por: Arora, Prerna, et al.
Publicado: (2022)

Genomic surveillance of SARS-CoV-2 during the first year of the pandemic in the Bronx enabled clinical and epidemiological inference
por: Fels, J. Maximilian, et al.
Publicado: (2022)

Genomic surveillance of SARS-CoV-2 during the first year of the pandemic in the Bronx enabled clinical and epidemiological inference
por: Fels, J. Maximilian, et al.
Publicado: (2022)

Detection of the Omicron Variant Virus With the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay
por: Regan, James, et al.
Publicado: (2022)

Isolation and Genomic Characterization of SARS-CoV-2 Omicron Variant Obtained from Human Clinical Specimens
por: Yadav, Pragya D., et al.
Publicado: (2022)

Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response
por: Shalamova, Lyudmila, et al.
Publicado: (2022)

Structural Insight into the Resistance of the SARS-CoV-2 Omicron BA.4 and BA.5 Variants to Cilgavimab
por: Fujita, Shigeru, et al.
Publicado: (2022)

SARS-CoV-2 Infection in Unvaccinated High-Risk Pregnant Women in the Bronx, NY, USA Is Associated with Decreased Apgar Scores and Placental Villous Infarcts
por: Reznik, Sandra E., et al.
Publicado: (2023)

The First Identification in Italy of SARS-CoV-2 Omicron BA.4 Harboring KSF141_del: A Genomic Comparison with Omicron Sub-Variants
por: Peronace, Cinzia, et al.
Publicado: (2022)

Properties of the Omicron Variant of SARS-CoV-2 Affect Public Health Measure Effectiveness in the COVID-19 Epidemic
por: Furuse, Yuki
Publicado: (2022)

Omicron Variant Generates a Higher and More Sustained Viral Load in Nasopharynx and Saliva Than the Delta Variant of SARS-CoV-2
por: Granerud, Beathe K., et al.
Publicado: (2022)

In-Silico Analysis of Monoclonal Antibodies against SARS-CoV-2 Omicron
por: Hu, Ye-Fan, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance
por: Guo, Yifei, et al.
Publicado: (2022)

Epidemiological characteristics of Omicron and Delta SARS-CoV-2 variant infection in Santiago, Chile
por: Mella-Torres, Andrea, et al.
Publicado: (2022)

Epidemiological Surveillance Reveals the Rise and Establishment of the Omicron SARS-CoV-2 Variant in Brazil
por: Silva, Joice do Prado, et al.
Publicado: (2023)

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
por: Gruell, Henning, et al.
Publicado: (2022)

Importation and Transmission of SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern in Korea, November 2021
por: Lee, Ji Joo, et al.
Publicado: (2021)

Clinical Characteristics of Patients Who Contracted the SARS-CoV-2 Omicron Variant from an Outbreak in a Single Hospital
por: Sohn, Yu Jin, et al.
Publicado: (2022)

Acute odynophagia: A new symptom of COVID‐19 during the SARS‐CoV‐2 Omicron variant wave in Sweden
por: Piersiala, Krzysztof, et al.
Publicado: (2022)

Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant
por: Sitaras, Ioannis, et al.
Publicado: (2022)

A Small Molecule That In Vitro Neutralizes Infection of SARS-CoV-2 and Its Most Infectious Variants, Delta, and Omicron
por: Reyes-Alcaraz, Arfaxad, et al.
Publicado: (2023)

SARS-CoV-2 Omicron BA.2.75 Variant May Be Much More Infective than Preexisting Variants Based on In Silico Model
por: Sugano, Aki, et al.
Publicado: (2022)

Impact of Omicron Variant Infection on Assessment of Spike-Specific Immune Responses Using the EUROIMMUN Quan-T-Cell SARS-CoV-2 Assay and Roche Elecsys Anti-SARS-CoV-2-S
por: Ahmed, Mohamed I. M., et al.
Publicado: (2023)

Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75
por: Wang, Qian, et al.
Publicado: (2022)

Alpha and Omicron SARS-CoV-2 Adaptation in an Upper Respiratory Tract Model
por: Mathez, Gregory, et al.
Publicado: (2022)

Omicron variant in the current SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2022)

The mysterious origins of the Omicron variant of SARS-CoV-2
por: Du, Pei, et al.
Publicado: (2022)

Plasma Neutralization of the SARS-CoV-2 Omicron Variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3fu4os4la0kiguvphsngki7vg0